NCT05039983 2024-04-03
Study of Epigallocatechin-3-gallate (EGCG) for Supportive and Symptomatic Management in Patients With Esophageal Cancer
Shandong Cancer Hospital and Institute
Phase 1 Completed
Shandong Cancer Hospital and Institute
Johannes Gutenberg University Mainz
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital